Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Study of High-Dose-Rate Brachytherapy as Monotherapy for Prostate Cancer

NCT02346253 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT02346253
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02346253 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Study of High-Dose-Rate Brachytherapy as Monotherapy for Prostate Cancer
Lead sponsor
Stanford University
Phase
Not applicable
Overall status
Completed
Start date
January 13, 2015
Completion date
May 17, 2026
Enrollment
146 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate adenocarcinoma, stage i prostate cancer, stage iia prostate cancer, stage iib prostate cancer, stage iii prostate cancer